|
Re: It's Time For Zenith To Disclose
|
5
|
Zenith Epigenetics
|
Jan 31, 2017 10:03AM
|
|
Re: Theories Regarding The Drop
|
5
|
Resverlogix Corp.
|
Jun 22, 2017 04:21PM
|
|
Re: Curiouser and Curiouser....
|
5
|
Resverlogix Corp.
|
May 01, 2017 06:52PM
|
|
Re: Expectations for the AGM?
|
5
|
Zenith Epigenetics
|
Dec 10, 2020 01:52PM
|
|
Futility analysis
|
5
|
Resverlogix Corp.
|
Feb 08, 2017 10:23AM
|
|
Re: Breakthrough Therapy Designation Application
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 11:34AM
|
|
Re: IR - "but all I can tell you at the moment is that we believe we are making real progress towards achieving our goals."
|
5
|
Resverlogix Corp.
|
May 17, 2023 02:42PM
|
|
Re: No news
|
5
|
Resverlogix Corp.
|
Sep 17, 2022 11:56AM
|
|
Re: Almost 1.25 years now
|
5
|
Zenith Epigenetics
|
May 31, 2018 04:29PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
5
|
Resverlogix Corp.
|
Aug 24, 2024 08:40AM
|
|
Zacks new analyst research update price increase and buy rating
|
5
|
Resverlogix Corp.
|
Jan 19, 2016 12:37PM
|
|
Re: Vote reminder
|
5
|
Zenith Epigenetics
|
Oct 24, 2023 10:07AM
|
|
Re: Here's what I'd like to see - a 1:5 Reverse coupled with a listing on the Naz
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 10:42AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
5
|
Zenith Epigenetics
|
Jan 30, 2019 10:14AM
|
|
Re: Special Meetings for RVX and Zenith are 6/30 starting at 9AM Calgary time
|
5
|
Resverlogix Corp.
|
Jun 27, 2015 12:44PM
|
|
Re: Heart failure study
|
5
|
Resverlogix Corp.
|
Feb 09, 2021 12:18PM
|
|
Institutional buying??
|
5
|
Resverlogix Corp.
|
Feb 14, 2018 02:12PM
|
|
Re: Theories Regarding The Drop
|
5
|
Resverlogix Corp.
|
Jun 22, 2017 10:59PM
|
|
Re: Lobbying
|
5
|
Resverlogix Corp.
|
May 17, 2022 08:36PM
|
|
Re: And we wait.....
|
5
|
Zenith Epigenetics
|
Jan 23, 2018 02:40PM
|
